You are here

Michael Sela

Prof. Michael Sela
04.02.2019

Prof. Michael Sela has received the 2018 Ot Yakir (tribute for his contribution) from the Movement for Quality Government in Israel

...

YEDA
16.03.2016

Portrazza is approved to by the US FDA to treat lung cancer

Two Antibodies Are Better Than One
07.02.2013

A new approach mimicking the body’s natural defenses could help treat a...

Profs. Bernardo Vidne and Talila Volk. From human hearts to fruit fly hearts
02.04.2012

After a career as a top cardiac surgeon, Prof. Bernardo Vidne decided to get a Ph.D. in science

Prof. Michael Sela
13.02.2011

Prof. Michael Sela was promoted to Commander in the National Order of the Legion of Honour by decree of the President of the French Republic...

Prof. Michael Sela
10.10.2010
from the institute to Teva Pharmaceuticals Ltd.
Prof. Sara Fuchs
01.10.2009
Prof. Sara Fuchs recalls the beginnnings of her life as a scientist at the Institute
Prof. Ruth Arnon
01.05.2009
From student to Institute Vice President
Genes that affect reponses of MS to Copaxone
10.10.2007

Israeli scientists identify: Genes that Affect Responses of Multiple Sclerosis Patients to Copaxone®

...

Pages